分子品質管理のグローバル市場:製品種類別、分析対象物種類別、用途別、エンドユーザー別

◆英語タイトル:Molecular Quality Controls Market Outlook by Product Type (Independent Controls, Instrument-Specific Controls), Analyte Type (Single-Analyte, Multi-Analyte), Application (Infectious Disease Diagnosis, Oncology Testing, Genetic Testing), End User (Diagnostic Laboratories, Hospitals, IVD Kit Manufacturers & CROs, Academic and Research Institutes) - Global Industry Growth and Demand Forecast to 2030

P&S Market Researchが発行した調査報告書(PS23SEP050)◆商品コード:PS23SEP050
◆発行会社(リサーチ会社):P&S Market Research
◆発行日:2023年2月
◆ページ数:280
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
5 UserUSD6,400 ⇒換算¥972,800見積依頼/購入/質問フォーム
Enterprise UserUSD8,400 ⇒換算¥1,276,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

P&S Intelligence社の発表によると、分子品質管理市場の総規模は2022年に1億9,120万米ドルで、2030年には3億1,370万米ドルに達し、今後6.4%のペースで成長する見込みです。2022年には、独立制御機器カテゴリーが約40%の最大シェアを占めています。これは、検量線、機器、試薬から独立して製造され、検査システムまたは技術の性能の非常に正確で偏りのない独立した評価の結果、最高の感度率を持つという事実によるものです。
2022年には、単一分析値のコントロールカテゴリーが60%以上のシェアを占めており、今後も同じシェアを維持するでしょう。これは、病院がシングルプレックスアッセイを使用することが多いためで、シングル分析物を使用することで、調査や理解が容易になり、交差反応の可能性が減少するなどの利点があります。

マルチアナライテは、今後数年間は7%程度の安定した成長率を示すでしょう。これは、技術の進歩と新しいマルチ分析およびマルチ機器コントロールの拡大によるものです。臨床検査室は、頻繁に使用される装置固有の制御を1台の装置に統合したこれらの最新装置を使用することで、コストを削減することができます。さらに、分析物ごとに個別の品質管理を行う必要がなくなるため、これらの管理による時間消費も少なくなります。

2022年の分子品質管理市場は、診断ラボが約35%を占めました。これは、分子技術を利用したサービスに集中する多数の認定ラボが異地域に存在すること、QC手順の採用頻度が高いこと、規制措置がより定期的に行われていること、分子診断がより高価になっていること、アルツハイマー、糖尿病、癌の症例が増加しており、毎年多数のラボの開設につながっているという事実によるものです。

2022年には北米が約45%で業界を支配しました。これは、最先端のインフラが多く導入されていること、診断施設が充実していること、この地域の認定臨床検査機関の数が増加していることによります。さらに、カナダと米国の最先端の医療施設、トップメーカーの存在、改良された製品や技術への容易なアクセスが、この地域の市場を牽引しています。北米では、患者人口が多い米国が高収益を上げました。ヨーロッパは北米に続いています。これは主に、雪だるま式に増加するがん研究と関連バイオマーカー、およびがん患者の増加によるものです。ある調査によると、ヨーロッパでは高齢者人口が増加しており、長引く病気にかかりやすいため、がんの有病率が急上昇するとのことです。認定臨床検査機関の数が増加しているため、分子品質管理の需要は今後数年間で増加する見込みです。

第1章.調査範囲
第2章.調査方法
第3章.エグゼクティブサマリー
第4章.産業専門家の意見/KOL
第5章.市場指標
第6章.産業動向
第7章.世界市場
第8章.北米市場
第9章.ヨーロッパ市場
第10章.アジア太平洋市場
第11章.中南米市場
第12章.中東・アフリカ市場
第13章.アメリカ市場
第14章.カナダ市場
第15章.ドイツ市場
第16章.フランス市場
第17章.イギリス市場
第18章.イタリア市場
第19章.スペイン市場
第20章.日本市場
第21章.中国市場
第22章.インド市場
第23章.オーストラリア市場
第24章.韓国市場
第25章.ブラジル市場
第26章.メキシコ市場
第27章.サウジアラビア市場
第28章.南アフリカ市場
第29章.中東市場
第30章.競争状況
第31章.企業情報
第32章.付録

❖ レポートの目次 ❖

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by product type

1.4.2. Market size breakdown, by analyte type

1.4.3. Market size breakdown, by application

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

6.1. Market Dynamics

6.1.1. Trends

6.1.2. Drivers

6.1.3. Restraints/challenges

6.1.4. Impact analysis of drivers/restraints

6.2. Impact of COVID-19

6.3. Porter’s Five Forces Analysis

6.3.1. Bargaining power of buyers

6.3.2. Bargaining power of suppliers

6.3.3. Threat of new entrants

6.3.4. Intensity of rivalry

6.3.5. Threat of substitutes

Chapter 7. Global Market

7.1. Overview

7.2. Market Revenue, by Product Type (2017–2030)

7.2.1. Instrument-specific controls market revenue, by type (2017–2030)

7.3. Market Revenue, by Analyte Type (2017–2030)

7.4. Market Revenue, by Application (2017–2030)

7.5. Market Revenue, by End User (2017–2030)

7.6. Market Revenue, by Region (2017–2030)

Chapter 8. North America Market

8.1. Overview

8.2. Market Revenue, by Product Type (2017–2030)

8.2.1. Instrument-specific controls market revenue, by type (2017–2030)

8.3. Market Revenue, by Analyte Type (2017–2030)

8.4. Market Revenue, by Application (2017–2030)

8.5. Market Revenue, by End User (2017–2030)

8.6. Market Revenue, by Country (2017–2030)

Chapter 9. Europe Market

9.1. Overview

9.2. Market Revenue, by Product Type (2017–2030)

9.2.1. Instrument-specific controls market revenue, by type (2017–2030)

9.3. Market Revenue, by Analyte Type (2017–2030)

9.4. Market Revenue, by Application (2017–2030)

9.5. Market Revenue, by End User (2017–2030)

9.6. Market Revenue, by Country (2017–2030)

Chapter 10. APAC Market

10.1. Overview

10.2. Market Revenue, by Product Type (2017–2030)

10.2.1. Instrument-specific controls market revenue, by type (2017–2030)

10.3. Market Revenue, by Analyte Type (2017–2030)

10.4. Market Revenue, by Application (2017–2030)

10.5. Market Revenue, by End User (2017–2030)

10.6. Market Revenue, by Country (2017–2030)

Chapter 11. LATAM Market

11.1. Overview

11.2. Market Revenue, by Product Type (2017–2030)

11.2.1. Instrument-specific controls market revenue, by type (2017–2030)

11.3. Market Revenue, by Analyte Type (2017–2030)

11.4. Market Revenue, by Application (2017–2030)

11.5. Market Revenue, by End User (2017–2030)

11.6. Market Revenue, by Country (2017–2030)

Chapter 12. MEA Market

12.1. Overview

12.2. Market Revenue, by Product Type (2017–2030)

12.2.1. Instrument-specific controls market revenue, by type (2017–2030)

12.3. Market Revenue, by Analyte Type (2017–2030)

12.4. Market Revenue, by Application (2017–2030)

12.5. Market Revenue, by End User (2017–2030)

12.6. Market Revenue, by Country (2017–2030)

Chapter 13. U.S. Market

13.1. Overview

13.2. Market Revenue, by Product Type (2017–2030)

13.2.1. Instrument-specific controls market revenue, by type (2017–2030)

13.3. Market Revenue, by Analyte Type (2017–2030)

13.4. Market Revenue, by Application (2017–2030)

13.5. Market Revenue, by End User (2017–2030)

Chapter 14. Canada Market

14.1. Overview

14.2. Market Revenue, by Product Type (2017–2030)

14.2.1. Instrument-specific controls market revenue, by type (2017–2030)

14.3. Market Revenue, by Analyte Type (2017–2030)

14.4. Market Revenue, by Application (2017–2030)

14.5. Market Revenue, by End User (2017–2030)

Chapter 15. Germany Market

15.1. Overview

15.2. Market Revenue, by Product Type (2017–2030)

15.2.1. Instrument-specific controls market revenue, by type (2017–2030)

15.3. Market Revenue, by Analyte Type (2017–2030)

15.4. Market Revenue, by Application (2017–2030)

15.5. Market Revenue, by End User (2017–2030)

Chapter 16. France Market

16.1. Overview

16.2. Market Revenue, by Product Type (2017–2030)

16.2.1. Instrument-specific controls market revenue, by type (2017–2030)

16.3. Market Revenue, by Analyte Type (2017–2030)

16.4. Market Revenue, by Application (2017–2030)

16.5. Market Revenue, by End User (2017–2030)

Chapter 17. U.K. Market

17.1. Overview

17.2. Market Revenue, by Product Type (2017–2030)

17.2.1. Instrument-specific controls market revenue, by type (2017–2030)

17.3. Market Revenue, by Analyte Type (2017–2030)

17.4. Market Revenue, by Application (2017–2030)

17.5. Market Revenue, by End User (2017–2030)

Chapter 18. Italy Market

18.1. Overview

18.2. Market Revenue, by Product Type (2017–2030)

18.2.1. Instrument-specific controls market revenue, by type (2017–2030)

18.3. Market Revenue, by Analyte Type (2017–2030)

18.4. Market Revenue, by Application (2017–2030)

18.5. Market Revenue, by End User (2017–2030)

Chapter 19. Spain Market

19.1. Overview

19.2. Market Revenue, by Product Type (2017–2030)

19.2.1. Instrument-specific controls market revenue, by type (2017–2030)

19.3. Market Revenue, by Analyte Type (2017–2030)

19.4. Market Revenue, by Application (2017–2030)

19.5. Market Revenue, by End User (2017–2030)

Chapter 20. Japan Market

20.1. Overview

20.2. Market Revenue, by Product Type (2017–2030)

20.2.1. Instrument-specific controls market revenue, by type (2017–2030)

20.3. Market Revenue, by Analyte Type (2017–2030)

20.4. Market Revenue, by Application (2017–2030)

20.5. Market Revenue, by End User (2017–2030)

Chapter 21. China Market

21.1. Overview

21.2. Market Revenue, by Product Type (2017–2030)

21.2.1. Instrument-specific controls market revenue, by type (2017–2030)

21.3. Market Revenue, by Analyte Type (2017–2030)

21.4. Market Revenue, by Application (2017–2030)

21.5. Market Revenue, by End User (2017–2030)

Chapter 22. India Market

22.1. Overview

22.2. Market Revenue, by Product Type (2017–2030)

22.2.1. Instrument-specific controls market revenue, by type (2017–2030)

22.3. Market Revenue, by Analyte Type (2017–2030)

22.4. Market Revenue, by Application (2017–2030)

22.5. Market Revenue, by End User (2017–2030)

Chapter 23. Australia Market

23.1. Overview

23.2. Market Revenue, by Product Type (2017–2030)

23.2.1. Instrument-specific controls market revenue, by type (2017–2030)

23.3. Market Revenue, by Analyte Type (2017–2030)

23.4. Market Revenue, by Application (2017–2030)

23.5. Market Revenue, by End User (2017–2030)

Chapter 24. South Korea Market

24.1. Overview

24.2. Market Revenue, by Product Type (2017–2030)

24.2.1. Instrument-specific controls market revenue, by type (2017–2030)

24.3. Market Revenue, by Analyte Type (2017–2030)

24.4. Market Revenue, by Application (2017–2030)

24.5. Market Revenue, by End User (2017–2030)

Chapter 25. Brazil Market

25.1. Overview

25.2. Market Revenue, by Product Type (2017–2030)

25.2.1. Instrument-specific controls market revenue, by type (2017–2030)

25.3. Market Revenue, by Analyte Type (2017–2030)

25.4. Market Revenue, by Application (2017–2030)

25.5. Market Revenue, by End User (2017–2030)

Chapter 26. Mexico Market

26.1. Overview

26.2. Market Revenue, by Product Type (2017–2030)

26.2.1. Instrument-specific controls market revenue, by type (2017–2030)

26.3. Market Revenue, by Analyte Type (2017–2030)

26.4. Market Revenue, by Application (2017–2030)

26.5. Market Revenue, by End User (2017–2030)

Chapter 27. Saudi Arabia Market

27.1. Overview

27.2. Market Revenue, by Product Type (2017–2030)

27.2.1. Instrument-specific controls market revenue, by type (2017–2030)

27.3. Market Revenue, by Analyte Type (2017–2030)

27.4. Market Revenue, by Application (2017–2030)

27.5. Market Revenue, by End User (2017–2030)

Chapter 28. South Africa Market

28.1. Overview

28.2. Market Revenue, by Product Type (2017–2030)

28.2.1. Instrument-specific controls market revenue, by type (2017–2030)

28.3. Market Revenue, by Analyte Type (2017–2030)

28.4. Market Revenue, by Application (2017–2030)

28.5. Market Revenue, by End User (2017–2030)

Chapter 29. U.A.E. Market

29.1. Overview

29.2. Market Revenue, by Product Type (2017–2030)

29.2.1. Instrument-specific controls market revenue, by type (2017–2030)

29.3. Market Revenue, by Analyte Type (2017–2030)

29.4. Market Revenue, by Application (2017–2030)

29.5. Market Revenue, by End User (2017–2030)

Chapter 30. Competitive Landscape

30.1. List of Market Players and their Offerings

30.2. Competitive Benchmarking of Key Players

30.3. Product Benchmarking of Key Players

30.4. Recent Strategic Developments

Chapter 31. Company Profiles

31.1. LGC Limited

31.1.1. Business overview

31.1.2. Product and service offerings

31.2. Thermo Fisher Scientific Inc.

31.2.1. Business overview

31.2.2. Product and service offerings

31.2.3. Key financial summary

31.3. Bio-Rad Laboratories Inc.

31.3.1. Business overview

31.3.2. Product and service offerings

31.3.3. Key financial summary

31.4. F. Hoffmann-La Roche Ltd.

31.4.1. Business overview

31.4.2. Product and service offerings

31.4.3. Key financial summary

31.5. ZeptoMetrix LLC

31.5.1. Business overview

31.5.2. Product and service offerings

31.6. Quidel Corporation

31.6.1. Business overview

31.6.2. Product and service offerings

31.6.3. Key financial summary

31.7. Maine Molecular Quality Controls Inc.

31.7.1. Business overview

31.7.2. Product and service offerings

31.8. Microbiologics Inc.

31.8.1. Business overview

31.8.2. Product and service offerings

31.9. Bio-Techne Corporation

31.9.1. Business overview

31.9.2. Product and service offerings

31.9.3. Key financial summary

31.10. Qnostics Ltd.

31.10.1. Business overview

31.10.2. Product and service offerings

31.11. Fortress Diagnostics

31.11.1. Business overview

31.11.2. Product and service offerings

31.12. LGC Clinical Diagnostics Inc.

31.12.1. Business overview

31.12.2. Product and service offerings

31.13. Microbix Biosystems Inc.

31.13.1. Business overview

31.13.2. Product and service offerings

31.13.3. Key financial summary

31.14. bioMérieux SA

31.14.1. Business overview

31.14.2. Product and service offerings

31.14.3. Key financial summary

31.15. Anchor Molecular

31.15.1. Business overview

31.15.2. Product and service offerings

Chapter 32. Appendix

32.1. Abbreviations

32.2. Sources and References

32.3. Related Reports

LIST OF FIGURES

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)

FIG 8 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 THREAT OF NEW ENTRANTS

FIG 12 INTENSITY OF RIVALRY

FIG 13 THREAT OF SUBSTITUTES

FIG 14 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 15 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 16 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 17 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 18 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 19 MAJOR WORLDWIDE MARKETS FOR MOLECULAR QUALITY CONTROLS, $M

FIG 20 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 21 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 22 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 23 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 24 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 25 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 26 EUROPE MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 27 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 28 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 29 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 30 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 31 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 32 APAC MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 33 APAC MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 34 APAC MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 35 APAC MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 36 APAC MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 37 APAC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 38 LATAM MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 39 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 40 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 41 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 42 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 43 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 44 MEA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 45 MEA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 46 MEA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 47 MEA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 48 MEA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 49 MEA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 50 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 51 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 52 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 53 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 54 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 55 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 56 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 57 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 58 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 59 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 60 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 61 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 62 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 63 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 64 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 65 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 66 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 67 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 68 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 69 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 70 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 71 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 72 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 73 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 74 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 75 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 76 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 77 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 78 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 79 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 80 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 81 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 82 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 83 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 84 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 85 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 86 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 87 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 88 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 89 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 90 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 91 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 92 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 93 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 94 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 95 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 96 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 97 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 98 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 99 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 100 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 101 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 102 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 103 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 104 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 105 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 106 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 107 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 108 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 109 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 110 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 111 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 112 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 113 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 114 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 115 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 116 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 117 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 118 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 119 BIO-RAD LABORATORIES INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 120 F. HOFFMANN-LA ROCHE LTD. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 121 QUIDEL CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 122 BIO-TECHNE CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 123 MICROBIX BIOSYSTEMS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 124 BIOMÉRIEUX SA – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 分子品質管理のグローバル市場:製品種類別、分析対象物種類別、用途別、エンドユーザー別(Molecular Quality Controls Market Outlook by Product Type (Independent Controls, Instrument-Specific Controls), Analyte Type (Single-Analyte, Multi-Analyte), Application (Infectious Disease Diagnosis, Oncology Testing, Genetic Testing), End User (Diagnostic Laboratories, Hospitals, IVD Kit Manufacturers & CROs, Academic and Research Institutes) - Global Industry Growth and Demand Forecast to 2030)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆